CareLit · DOI-Nachweis · Klinische Neurophysiologie
4-Aminopyridine improves gait variability and reduces fall risk in patients with cerebellar gait disorders
DOI 10.1055/s-0032-1301685
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Schniepp, M Wühr, K Jahn
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The fall risk of patients with cerebellar disorders is markedly increased. These falls cause immobility due to serious injuries or a fear of falling. Therefore, reducing the fall risk is the major goal in symptomatic treatment of cerebellar gait disorders. We examined the effect of the potassium channel blocker 4-aminopyridine (4-AP) on the gait performance of patients with different cerebellar syndromes. Pati…
Zitieren
Zitierempfehlung
R Schniepp, M Wühr, K Jahn (2012) 4-Aminopyridine improves gait variability and reduces fall risk in patients with cerebellar gait disorders. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-0032-1301685
Mit CareLit weiterarbeiten